Gennex Laboratories Limited (GENNEX.BO)
INR 13.85
(0.44%)
INR 13.85
(0.44%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 867.14 Million INR | 32.18% |
| 2022 | 656.03 Million INR | 7.23% |
| 2021 | 611.79 Million INR | 2.6% |
| 2020 | 596.26 Million INR | 7.26% |
| 2019 | 555.87 Million INR | -0.33% |
| 2018 | 557.72 Million INR | 27.65% |
| 2017 | 436.9 Million INR | 4.25% |
| 2016 | 419.07 Million INR | 8.69% |
| 2015 | 385.56 Million INR | 20.88% |
| 2014 | 318.96 Million INR | -8.84% |
| 2013 | 349.89 Million INR | 16.92% |
| 2012 | 299.24 Million INR | 21.82% |
| 2011 | 245.64 Million INR | 24.21% |
| 2010 | 197.77 Million INR | 28.05% |
| 2009 | 154.45 Million INR | 0.93% |
| 2008 | 153.03 Million INR | -31.37% |
| 2007 | 222.98 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 283.21 Million INR | -15.46% |
| 2023 Q2 | 175.79 Million INR | 6.62% |
| 2023 Q3 | 213.97 Million INR | 21.72% |
| 2023 Q4 | 335.02 Million INR | 56.57% |
| 2023 FY | 867.14 Million INR | 32.18% |
| 2023 Q1 | 164.88 Million INR | -11.62% |
| 2022 Q2 | 191.13 Million INR | 37.14% |
| 2022 FY | 656.03 Million INR | 7.23% |
| 2022 Q1 | 139.37 Million INR | -30.81% |
| 2022 Q4 | 186.56 Million INR | 34.26% |
| 2022 Q3 | 138.95 Million INR | -27.3% |
| 2021 Q3 | 166.83 Million INR | 16.73% |
| 2021 FY | 611.79 Million INR | 2.6% |
| 2021 Q2 | 142.92 Million INR | 37.78% |
| 2021 Q1 | 103.72 Million INR | -36.1% |
| 2021 Q4 | 201.43 Million INR | 20.74% |
| 2020 FY | 596.26 Million INR | 7.26% |
| 2020 Q4 | 162.33 Million INR | 5.05% |
| 2020 Q3 | 154.53 Million INR | 3.45% |
| 2020 Q2 | 149.37 Million INR | 14.5% |
| 2020 Q1 | 130.46 Million INR | 14.2% |
| 2019 Q3 | 146.8 Million INR | 9.59% |
| 2019 Q1 | 160.87 Million INR | -20.87% |
| 2019 Q2 | 133.96 Million INR | -16.73% |
| 2019 Q4 | 114.23 Million INR | -22.19% |
| 2019 FY | 555.87 Million INR | -0.33% |
| 2018 Q1 | 94.44 Million INR | -29.9% |
| 2018 Q3 | 152.15 Million INR | 41.12% |
| 2018 Q4 | 203.3 Million INR | 33.62% |
| 2018 FY | 557.72 Million INR | 27.65% |
| 2018 Q2 | 107.81 Million INR | 14.15% |
| 2017 Q4 | 134.72 Million INR | 13.35% |
| 2017 Q3 | 118.86 Million INR | 13.21% |
| 2017 Q2 | 104.99 Million INR | 32.55% |
| 2017 Q1 | 79.2 Million INR | -28.53% |
| 2017 FY | 436.9 Million INR | 4.25% |
| 2016 Q3 | 105.84 Million INR | -15.63% |
| 2016 Q1 | 76.95 Million INR | -22.68% |
| 2016 FY | 419.07 Million INR | 8.69% |
| 2016 Q2 | 125.44 Million INR | 63.0% |
| 2016 Q4 | 110.82 Million INR | 4.71% |
| 2015 FY | 385.56 Million INR | 20.88% |
| 2015 Q2 | 102.53 Million INR | 10.64% |
| 2015 Q4 | 99.52 Million INR | 9.59% |
| 2015 Q3 | 90.81 Million INR | -11.43% |
| 2015 Q1 | 92.67 Million INR | 0.17% |
| 2014 Q4 | 92.51 Million INR | 39.42% |
| 2014 FY | 318.96 Million INR | -8.84% |
| 2014 Q1 | 77.02 Million INR | -22.32% |
| 2014 Q2 | 83.06 Million INR | 7.84% |
| 2014 Q3 | 66.35 Million INR | -20.12% |
| 2013 Q3 | 102.12 Million INR | 26.5% |
| 2013 FY | 349.89 Million INR | 16.92% |
| 2013 Q2 | 80.73 Million INR | 19.05% |
| 2013 Q1 | 67.81 Million INR | -19.01% |
| 2013 Q4 | 99.16 Million INR | -2.9% |
| 2012 FY | 299.24 Million INR | 21.82% |
| 2012 Q1 | 72.72 Million INR | 19.95% |
| 2012 Q4 | 83.72 Million INR | 4.65% |
| 2012 Q3 | 80 Million INR | 26.65% |
| 2012 Q2 | 63.17 Million INR | -13.13% |
| 2011 FY | 245.64 Million INR | 24.21% |
| 2011 Q4 | 60.63 Million INR | -14.73% |
| 2011 Q3 | 71.1 Million INR | 0.0% |
| 2010 FY | 197.77 Million INR | 28.05% |
| 2010 Q4 | 38.47 Million INR | 0.0% |
| 2009 FY | 154.45 Million INR | 0.93% |
| 2008 FY | 153.03 Million INR | -31.37% |
| 2008 Q4 | 26.24 Million INR | 0.0% |
| 2007 FY | 222.98 Million INR | 0.0% |
| 2007 Q4 | 59.07 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Phaarmasia Limited | 305.93 Million INR | -183.442% |
| ANG Lifesciences India Limited | 1.46 Billion INR | 40.651% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 57.09% |
| Bacil Pharma Limited | - INR | -Infinity% |
| BDH Industries Limited | 858.31 Million INR | -1.029% |
| Beryl Drugs Limited | 271.24 Million INR | -219.688% |
| Cian Healthcare Limited | 616.95 Million INR | -40.552% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -4617.354% |
| Colinz Laboratories Limited | 70.29 Million INR | -1133.561% |
| Concord Drugs Limited | 449.24 Million INR | -93.023% |
| Deccan Health Care Limited | 597.28 Million INR | -45.18% |
| DECIPHER LABS LIMITED | 362.75 Million INR | -139.045% |
| Denis Chem Lab Limited | 1.67 Billion INR | 48.33% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | -80.75% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 48.938% |
| Hindustan Bio Sciences Limited | 10.48 Million INR | -8166.753% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -470.955% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 38.919% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 17.318% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 71.77% |
| Makers Laboratories Limited | 1.03 Billion INR | 16.431% |
| Medi-Caps Limited | 265.63 Million INR | -226.442% |
| MedPlus Health Services Limited | 56.24 Billion INR | 98.458% |
| Panchsheel Organics Limited | 1.05 Billion INR | 17.587% |
| Parmax Pharma Limited | 154.24 Million INR | -462.192% |
| Parnax Lab Limited | 1.88 Billion INR | 54.049% |
| Patidar Buildcon Limited | 2.3 Million INR | -37471.231% |
| PRAVEG LIMITED | 915.96 Million INR | 5.33% |
| Mercury Laboratories Limited | 755.59 Million INR | -14.764% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | -61.518% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 93.605% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -77462.075% |
| Smruthi Organics Limited | 1.27 Billion INR | 32.065% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | -217.672% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 81.293% |
| Sunil Healthcare Limited | 901.91 Million INR | 3.856% |
| Syschem (India) Limited | 2.33 Billion INR | 62.868% |
| Trident Lifeline Limited | 446.28 Million INR | -94.302% |
| Transchem Limited | 4.09 Million INR | -21049.859% |
| Trinity League India Limited | 2.95 Million INR | -29294.712% |
| Tyche Industries Limited | 696.83 Million INR | -24.44% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | 30.856% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -742.886% |
| Vivanza Biosciences Limited | 278.89 Million INR | -210.925% |
| Zenith Healthcare Limited | 144.71 Million INR | -499.2% |
| Zenlabs Ethica Limited | 585.63 Million INR | -48.07% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | -116.662% |
| Vasundhara Rasayans Limited | 370.18 Million INR | -134.247% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | -94.387% |
| Roopa Industries Limited | 715.53 Million INR | -21.188% |
| PANJON LTD. | 125.52 Million INR | -590.836% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -473.808% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 86.598% |
| Crestchem Limited | 212.56 Million INR | -307.949% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -15518.588% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | -28.885% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 75.093% |
| Trimurthi Limited | 42.23 Million INR | -1952.995% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | -16.281% |
| Norris Medicines Limited | 56.35 Million INR | -1438.686% |
| Veerhealth Care Limited | 142.13 Million INR | -510.089% |
| Lactose (India) Limited | 1.13 Billion INR | 23.861% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | -118.743% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 50.258% |
| Godavari Drugs Limited | 1.56 Billion INR | 44.666% |
| Zenotech Laboratories Limited | 368.08 Million INR | -135.58% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | 31.122% |
| Bharat Parenterals Limited | 2.59 Billion INR | 66.572% |
| Coral Laboratories Limited | 836.6 Million INR | -3.65% |
| Evoq Remedies Limited | 63.09 Million INR | -1274.456% |
| Kerala Ayurveda Limited | 1.02 Billion INR | 15.265% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 44.206% |
| Auro Laboratories Limited | 526.99 Million INR | -64.545% |